With this fourth edition, Qualcomm reaffirms its commitment to empowering Africa’s deep-technology ecosystem through mentorship, training, and IP generation initiatives ...

By removing rare earths from the equation, these designs promise cleaner supply chains and more sustainable production.

Uganda’s TWave Ltd , who have pioneered an automated, solar‑powered fish feeding system that optimizes aquaculture ...

Uganda's TWave Ltd , who have pioneered an automated, solar-powered fish feeding system that optimizes aquaculture productivity, have been selected as one of 10 startups for the fourth year of the ...

This valuable work identifies a subpopulation of neurons in the larval zebrafish pallium that responds differentially to varying threat levels, potentially mediating the categorization of negative ...

Qualcomm Incorporated has unveiled 10 startups selected for the 2026 edition of its Make in Africa Mentorship Programme, reaffirming its commitment to advancing the continent’s deep-technology ...

Arduino has become one of the key building blocks of the open hardware movement. Arduino, the platform, is designed to be modular, affordable, and easy for virtually anyone to use. The company behind ...

Discover how to build a self-made mini hydroelectric station on a small river generating 600W of reliable electricity. See the DIY turbine, wooden bearings, and generator setup powering lights, ...

Everything on the electromagnetic spectrum has some properties of both waves and particles, but it’s difficult to imagine a radio wave, for example, behaving like a particle. The main evidence for ...

Wave Life Sciences (WVE) fell ~57% in the premarket on Thursday as Wall Street reacted to interim data from an early-stage trial for WVE-007, its RNA-based obesity medicine. Citing six-month follow-up ...

Catch a ride with one of the rising clubs of American soccer with our San Diego Wave TV schedule. One of NWSL’s newest clubs has not yet made a splash on the field, but they’ve emerged as a model for ...

Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down by more than 50% despite the biotech hailing the data as ...